U.S. PHARMACOPEIA

Search USP29  
Epinephrine Nasal Solution
» Epinephrine Nasal Solution is a solution of Epinephrine in Purified Water prepared with the aid of Hydrochloric Acid. It contains, in each 100 mL, not less than 90 mg and not more than 115 mg of C9H13NO3.
Packaging and storage— Preserve in small, well-filled, tight, light-resistant containers.
Labeling— The label indicates that the Nasal Solution is not to be used if its color is pinkish or darker than slightly yellow or if it contains a precipitate.
Color and clarity— Using the Nasal Solution as the Test solution, proceed as directed for Color and clarity under Epinephrine Injection.
Identification— To 5 mL of pH 4.0 acid phthalate buffer (see Buffer Solutions in the section Reagents, Indicators, and Solutions) add 0.5 mL of Nasal Solution and 1.0 mL of 0.1 N iodine. Mix, and allow to stand for 5 minutes. Add 2 mL of sodium thiosulfate solution (1 in 40): a deep red color is produced.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay— Pipet 30 mL of Nasal Solution into a 125-mL separator, add 25 mL of chloroform, shake vigorously for 1 minute, allow the liquids to separate, and discard the chloroform. Wash twice more with chloroform, separating and discarding the lower layer as completely as possible each time. Rinse the stopper and mouth of the separator with a few drops of water. Add 0.2 mL of starch TS, then while swirling the separator add iodine and potassium iodide TS 1 dropwise until the blue color formed persists, and immediately add just sufficient 0.1 N sodium thiosulfate to discharge the blue color. [NOTE—Proceed with the assay from this point without delay.]
Add to the liquid in the separator 2.10 g of sodium bicarbonate, preventing it from coming in contact with the mouth of the separator, and swirl until most of the bicarbonate has dissolved. By means of a 1-mL syringe that is not fitted with a needle, rapidly inject 1.0 mL of acetic anhydride directly into the contents of the separator. Immediately insert the stopper in the separator, and shake vigorously until the evolution of carbon dioxide has ceased (7 to 10 minutes), releasing the pressure as necessary through the stopcock. Allow to stand for 5 minutes, and extract the solution with six 25-mL portions of chloroform, filtering each extract through a small pledget of cotton, previously washed with chloroform, into a beaker.
Evaporate the combined chloroform extracts on a steam bath in a current of air to about 3 mL, transfer the residue by means of small portions of chloroform to a tared 50-mL beaker, and heat again to evaporate the solvent completely. Heat further at 105 for 30 minutes, cool in a desiccator, and weigh the residue of triacetylepinephrine. Add 5.0 mL of chloroform, cover the beaker, gently swirl the contents until the residue has completely dissolved, and determine the specific rotation, R, using a 200-mm semimicro polarimeter tube.
Calculate the quantity, in mg, of C9H13NO3 in the volume of Nasal Solution taken by the formula:
(183.20/309.32)(W)(0.5 + 0.5R / 93),
in which 183.20 and 309.32 are the molecular weights of epinephrine and triacetylepinephrine, respectively; and W is the weight, in mg, and R is the specific rotation (in degrees, without regard to the sign), of the isolated triacetylepinephrine.
Auxiliary Information— Staff Liaison : Kahkashan Zaidi, Ph.D., Senior Scientific Associate
Expert Committee : (AER05) Aerosols05
USP29–NF24 Page 808
Pharmacopeial Forum : Volume No. 30(4) Page 1192
Phone Number : 1-301-816-8269